Market News / Story

Prostatype Genomics has submitted additional responses in the Medicare review process – working meeting planned for November

MFN by Modular Finance ·

MFN by Modular Finance reports: Prostatype Genomics AB announces that this week the company submitted responses and clarifications to the latest questions in the ongoing process to secure Medicare reimbursement for Prostatype® in the United States. The questions concern a limited number of areas addressed in previous discussions, enabling the company to respond promptly. A working meeting within the MolDX program is planned for the first half of November 2026. The application is being…

VIEW SOURCE

Back to news